TERT促进子突变对预测脑膜瘤结果的影响:多机构队列分析
Karenna J Groff1, Ruchit V Patel2, Yang Feng3
1Department of Neurosurgery, NYU Langone Health and NYU Grossman School of Medicine, New York, NY, USA; Department of Pathology, NYU Langone Health and NYU Grossman School of Medicine, New York, NY, USA.
The Lancet. Oncology
|September 4, 2025
概括
脑膜瘤中的TERT促进基因突变并不总是表示具有攻击性的瘤. CDKN2A/B损失是预测预后的关键因素,特别是在世卫组织2级脑膜瘤中.
科学领域:
- 神经瘤学
- 分子病理学
- 基因组学
背景情况:
- 分子异常越来越多地用于脑膜瘤分类.
- TERT促成体 (TERTp) 突变与更差的预后和世卫组织3级指定有关.
- TERTp突变的预后影响可能取决于同时发生的基因变异.
研究的目的:
- 研究TERTp突变在脑膜瘤预后中的作用.
- 要确定TERTp突变是否依赖于环境.
- 为了指导TERTp测序的临床效用.
主要方法:
- 对1492名脑膜瘤患者进行多模式分析.
- 评估TERTp突变,CDKN2A/B损失和副本数量的变化.
- 卡普兰-梅尔曲线和多变量考克斯模型用于评估生存率和复发率.
主要成果:
- 在4. 3%的脑膜瘤中发现了TERTp突变.
- 有TERTp突变的脑膜瘤呈现异质分级和具有攻击性的分子特征,如1p和CDKN2A/B损失.
- CDKN2A/ B损失,而不是单独的TERTp突变,显著影响了整体存活率和无复发存活率.
结论:
- 单独的TERTp突变不足以确定最高级别的脑膜瘤.
- 当与其他分子标志物相结合时,TERT测序可以识别高风险的世卫组织2级脑膜瘤.
- 在TERTp突变脑膜瘤中,CDKN2A/B损失是攻击性行为的关键决定因素.
更多相关视频
09:33Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
Published on: August 25, 2023
1.2K
06:46Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
Published on: September 27, 2024
372
相关概念视频
Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Tumor Progression
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
